Bain Capital Private Equity

Founded in 1984, Bain Capital Private Equity focuses on making control and minority equity investments and prefers to make more substantial investments from a dollars perspective. Based in Boston, the firm invests in healthcare and several other industries, targeting companies with revenue of at least $100 million. Within healthcare, Bain Capital Private Equity targets companies in the provider services, hospital/major facilities, life sciences/pharmaceutical and non-reimbursement industries. Companies in its healthcare portfolio include Cerevel Therapeutics, a developer of therapies to treat central nervous system disorders; Aveanna Healthcare, a pediatric home healthcare provider in North America; Waystar, a revenue cycle technology provider; Grupo Notre Dame Intermedica, a healthcare provider in Brazil; and STADA, a European manufacturer of prescription generics.
Read more about Bain Capital Private Equity at